Verloes–Van Maldergem–Marneffe syndrome
Verloes–Van Maldergem–Marneffe syndrome is a rare genetic disorder characterized by a range of physical and developmental anomalies. This syndrome is named after the researchers who first described it, highlighting its rarity and the collaborative effort in its identification. The condition is part of a broader category of genetic disorders, which are caused by changes to the DNA sequence. Verloes–Van Maldergem–Marneffe syndrome is notable for its complex presentation, which can vary significantly among affected individuals.
Symptoms and Characteristics[edit | edit source]
The syndrome is marked by a constellation of symptoms, including but not limited to, intellectual disability, distinctive facial features, and skeletal abnormalities. Patients may also exhibit growth delays, both prenatally and postnatally. The facial features characteristic of Verloes–Van Maldergem–Marneffe syndrome include a prominent forehead, widely spaced eyes (hypertelorism), a broad nasal bridge, and a small chin (micrognathia). Skeletal anomalies might include scoliosis (curvature of the spine), joint hypermobility, and abnormalities in the hands and feet.
Genetics[edit | edit source]
Verloes–Van Maldergem–Marneffe syndrome is believed to be inherited in an autosomal recessive manner, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected by the syndrome. The specific genes involved in this syndrome have not been definitively identified, reflecting the complexity of genetic research in rare disorders. Genetic counseling is recommended for families with a history of the syndrome, as it can provide information on the risk of recurrence in future pregnancies.
Diagnosis[edit | edit source]
Diagnosis of Verloes–Van Maldergem–Marneffe syndrome is primarily based on clinical evaluation and the identification of characteristic symptoms. Genetic testing may aid in the diagnosis, although the absence of a clearly identified genetic marker can complicate this process. Early diagnosis is crucial for the management of symptoms and the provision of appropriate care and support to affected individuals and their families.
Management and Treatment[edit | edit source]
There is no cure for Verloes–Van Maldergem–Marneffe syndrome, and treatment is symptomatic and supportive. Management strategies may include physical therapy, special education programs, and surgical interventions to address specific anomalies. A multidisciplinary approach is often necessary to address the wide range of symptoms associated with the syndrome.
Prognosis[edit | edit source]
The prognosis for individuals with Verloes–Van Maldergem–Marneffe syndrome varies depending on the severity of symptoms and the presence of associated health issues. With appropriate care and support, many individuals with the syndrome can lead fulfilling lives.
See Also[edit | edit source]
Transform your life with W8MD's budget GLP1 injections from $125
W8MD offers a medical weight loss program NYC and a clinic to lose weight in Philadelphia. Our W8MD's physician supervised medical weight loss centers in NYC provides expert medical guidance, and offers telemedicine options for convenience.
Why choose W8MD?
- Comprehensive care with FDA-approved weight loss medications including:
- loss injections in NYC both generic and brand names:
- weight loss medications including Phentermine, Qsymia, Diethylpropion etc.
- Accept most insurances for visits or discounted self pay cost.
- Generic weight loss injections starting from just $125.00 for the starting dose
- In person weight loss NYC and telemedicine medical weight loss options in New York city available
- Budget GLP1 weight loss injections in NYC starting from $125.00 biweekly with insurance!
Book Your Appointment
Start your NYC weight loss journey today at our NYC medical weight loss, and Philadelphia medical weight loss Call (718)946-5500 for NY and 215 676 2334 for PA
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's NYC physician weight loss.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available. Call 718 946 5500.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD